Ziebarth D, Spiegelhalder B, Bartsch H
Max-Delbruck-Centrum, Berlin-Buch, Germany.
Carcinogenesis. 1997 Feb;18(2):383-9. doi: 10.1093/carcin/18.2.383.
Micro-organisms commonly present in human saliva and three DSM strains (Helicobacter pylori, Campylobacter jejuni and Neisseria cinerea), which can be isolated from the human gastro-intestinal tract, were assayed in vitro for their capacity to catalyse N-nitrosation of a series of medicinal drugs and other compounds. Following incubation at pH 7.2 in the presence of nitrate (or nitrite) for up to 24 (48) h, the yield of N-nitroso compounds (NOC) was quantified by HPLC equipped with a post-column derivatization device, allowing the sensitive detection of acid-labile and acid-stable NOC. Eleven out of the 23 test compounds underwent bacteria-catalysed nitrosation by salivary bacteria, the yield of the respective nitrosation products varying 800-fold. 4-(Methylamino)antipyrine exhibited the highest rate of nitrosation, followed by dichlofenac > metamizole > piperazine > five other drugs, whilst L-proline and L-thioproline had the lowest nitrosation rate. Ten drugs including aminophenazone, cimetidine and nicotine, did not inhibit bacterial growth, allowing transitory nitrite to be formed, but no N-nitroso derivatives were detected. Three drugs inhibited the proliferation of bacteria and neither nitrite nor any NOC were formed. Using metamizole as an easily nitrosatable precursor, two strains, Campylobacter jejuni and Helicobacter pylori, were shown to catalyse nitrosation in the presence of nitrite at pH 7.2. As compared to Neisseria cinerea used as a nitrosation-proficient control strain, H. pylori was 30-100 times less effective, whilst C. jejuni had intermediary activity. The results of our sensitive nitrosation assay further confirm that bacteria isolated from human sources, possessing nitrate reductase and/or nitrosating enzymes such as cytochrome cd1-nitrite reductase (Calmels et al., Carcinogenesis, 17, 533-536, 1996), can contribute to intragastric nitrosamine formation in the anacidic stomach when nitrosatable precursors from exogenous and endogenous sources are present.
对通常存在于人类唾液中的微生物以及三种可从人类胃肠道分离出的DSM菌株(幽门螺杆菌、空肠弯曲菌和灰色奈瑟菌)进行了体外测定,以检测它们催化一系列药物和其他化合物亚硝化反应的能力。在pH 7.2、存在硝酸盐(或亚硝酸盐)的条件下孵育长达24(48)小时后,通过配备柱后衍生装置的高效液相色谱法对亚硝基化合物(NOC)的产量进行定量,从而能够灵敏地检测酸不稳定和酸稳定的NOC。23种测试化合物中有11种受到唾液细菌催化的亚硝化反应影响,各自亚硝化产物的产量相差800倍。4-(甲氨基)安替比林的亚硝化速率最高,其次是双氯芬酸>安乃近>哌嗪>其他五种药物,而L-脯氨酸和L-硫代脯氨酸的亚硝化速率最低。包括氨基苯乙酮、西咪替丁和尼古丁在内的十种药物不抑制细菌生长,可使亚硝酸盐短暂形成,但未检测到亚硝基衍生物。三种药物抑制细菌增殖,既未形成亚硝酸盐也未形成任何NOC。以安乃近作为易于亚硝化的前体,空肠弯曲菌和幽门螺杆菌这两种菌株在pH 7.2、存在亚硝酸盐的情况下显示出催化亚硝化反应的能力。与用作亚硝化能力熟练对照菌株的灰色奈瑟菌相比,幽门螺杆菌的效率低30至100倍,而空肠弯曲菌具有中等活性。我们灵敏的亚硝化测定结果进一步证实,从人类来源分离出的、具有硝酸盐还原酶和/或亚硝化酶(如细胞色素cd1-亚硝酸盐还原酶,Calmels等人,《癌变》,17,533 - 536,1996)的细菌,当存在来自外源性和内源性来源的可亚硝化前体时,可导致无酸胃内亚硝胺的形成。